Tag Archives: Aileron

Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32

Section 32, which invests in healthcare and life sciences companies with a technology component, has added a third managing partner. The small venture capital firm was started in San Diego about two years ago by Bill Maris, who, during his time at Google, founded and led its corporate venture capital arm, now part of parent […]

Posted in Boston blog main, Boston top stories, National blog main, San Diego, San Diego blog main, San Diego top stories | Tagged , , , , , , , , , , , , , , , | Comments Off on Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32

Xconomy Boston’s Top 10 Stories from Q3 2013: Editor’s Picks

Herpes, PowerBars, and IPOs. Apple, Amazon, and acoustics. What more can you ask? Well, we’ve seen them all around town in the past three months. It’s the end of the third quarter, and with that, I’d like to highlight my 10 favorite Xconomy Boston stories from the period. They are a mix of company profiles, […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Xconomy Boston’s Top 10 Stories from Q3 2013: Editor’s Picks

New England’s Emerging Biotech Stars: An Xconomy Forum In Pictures

Hollywood may be famous for its movie stars, but the Boston area has its own crop of celebrities… in biotech, that is. We showcased which companies and entrepreneurs are the ones to watch this past Wednesday at our Xconomy Forum: New England’s Emerging Biotech Stars. Biogen Idec was a gracious event host—and provided some insightful […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories, OLD Boston slideshow | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

See You Today at New England’s Emerging Biotech Stars***SOLD OUT***

We’re about to get going on this afternoon’s Xconomy Forum: New England’s Emerging Biotech Stars. But you still have a few hours to get your tickets. We have 8 left as of early this morning, which you can grab by clicking here. We have a stellar lineup of speakers planned, including Biogen Idec CEO George […]

Posted in Boston, Boston blog main, National blog main | Tagged , , , , , , , , , , , , | Comments Off on See You Today at New England’s Emerging Biotech Stars***SOLD OUT***

Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation

Mark Levin co-founded Boston’s Third Rock Ventures in 2007 with the goal of funding life sciences discoveries through the Valley of Death—when early-stage startups are no longer eligible for federal grants but they haven’t progressed enough to attract the attention of VCs. Third Rock has launched and incubated eight startups, including Foundation Medicine, Warp Drive […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation

Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum

In 2010, biotech entrepreneur Chip Clark was looking for a new challenge after the company he co-founded, Vanda Pharmaceuticals in Washington, DC, completed a $200 million licensing deal with Novartis. When he was offered the opportunity to join Cambridge, MA-based vaccine developer Genocea Biosciences, he jumped. “I was acutely sensitive to the notion that the […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum

New England’s Emerging Biotech Stars: The Agenda

We’re just a month away from our next big biotech event in Boston, New England’s Emerging Biotech Stars. We have a stellar lineup planned for this afternoon event, which will be held April 4 at Biogen Idec in Cambridge, MA. Today we’re rolling out the official agenda for this exciting half-day conference. We’ll hear from […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on New England’s Emerging Biotech Stars: The Agenda

New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event

The life sciences industry is booming in the Boston area. Witness some of our headlines just over the past few weeks: Flagship Ventures closed a $270 million fund to invest in new biotech companies; startups RaNA and Warp Drive Bio raised significant VC rounds; pharma giant Merck led a $10 million financing of diagnostics firm […]

Posted in Boston, Boston blog main, Boston top stories, National blog main | Tagged , , , , , , , , , , , , , , , , , , , , , | Comments Off on New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event

2009’s Top 10 Private Equity Deals in Massachusetts: The List

Life sciences companies nabbed nine of the 10 largest private equity deals in the Boston area in 2009, a year when investors were called on to fund biotechs and medical devices companies in late stages of product development, according to a recent survey by Dow Jones VentureSource. The survey data indicate that private equity investors […]

Posted in Boston, Boston blog main, National blog main | Tagged , , , , , , , , , , , , , , , , | Comments Off on 2009’s Top 10 Private Equity Deals in Massachusetts: The List

Aileron Develops New Class of Drugs To Go Where None Could Before

If Aileron Therapeutics is on the right track, it will turn “stapled peptides” into a biotech industry buzzword along the lines of RNA interference. The Cambridge, MA-based company says its technology, like RNAi, is starting to show in animal tests that it can work against diseases where conventional drugs don’t. This company, whose name is […]

Posted in Boston, Boston blog main, National blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Aileron Develops New Class of Drugs To Go Where None Could Before